NASDAQ NMS - GLOBAL MARKET · GILD

-1.31% · -$1.79

Gilead Sciences, Inc

Biotechnology

$134.43

+ Add to watchlist

Veridion Score

BETAHIGH CONF · 5/6 factors

As of May 31, 9:12 AM EDT · GILD

Methodology

49/100

NEUTRAL

Composite intelligence score across six weighted factors. Higher score = stronger composite signal.

Score history: Coverage building

Institutional Flow · 90D

Corporate Insiders

SEC Form 4

30/ 100

-2.2M net shares (90d) · 40B / 18S

US Congress

Senate eFD + House STOCK Act

—/ 100

no data

Wall Street Analysts

Sell-side consensus

77/ 100

11 SB · 20 B · 8 H

Sovereign · $25/mo

See why this score moved.

· Factor breakdown with raw signals
· Day-over-day delta + driver
· Factor coverage readout
· Insider · Congress · Wall Street flow
· Pro Chart event markers
· Score history + alerts

Start Sovereign · $25/mo →

Cancel anytime · or Reserve · $79/mo

Confidence: HIGH · 5/6 factors with data · Computed May 31, 9:12 AM EDT · Refreshes hourly

Share on X →

Veridion Score History · 90D

Composite trend over time

LOADING HISTORY…

REFRESHES DAILY

AI Analysis

BETA

Why is GILD moving today?

Analyzing news articles + insider activity + analyst signals…

About Gilead Sciences, Inc

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Founded

—

Listed

1992

Employees

17K

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).

Company website →

Open

$135.13

Previous close

$136.22

Day high

$137.20

Day low

$133.54

Market cap

$166.90B

IPO

1992-01-22

Country

Currency

USD

Data ledger

Quote and day range

As of May 29, 4:00 PM EDT

Source: Market data

Veridion Score

As of May 31, 9:12 AM EDT

Source: Veridion methodology

Chart and risk context

Daily bars with no missing-bar fill

Source: Market data

News and filings

Refresh intervals shown inside each panel

Source: Market news and federal filings

Financials

Loading quarterly statements…

Insider activity · 6M

Loading Form 4 filings…

Congress · 90D

Loading PTR filings…

Federal contracts

GILD contract awards, year to date.

Public federal awards linked to this ticker.

—

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for GILD in this window.

Lobbying spend

GILD lobbying filings, year to date.

Registered lobbying filings matched to Gilead Sciences, Inc.

$5.3M

Refresh interval: 12hSource: LDA disclosure filings

Health Issues Budget/Appropriations Medicare/MedicaidTrade (domestic/foreign) Health Issues Medicare/Medicaid Copyright/Patent/Trademark Budget/Appropriations Taxation/Internal Revenue CodeHealth Issues

Filing

$3.2M

GILEAD SCIENCES INC

GILEAD SCIENCES, INC.

Apr 20, 2026

Filing

$1.7M

GILEAD SCIENCES INC

GILEAD SCIENCES, INC.

Jan 20, 2026

Filing

$150.0K